FASEB journal : official publication of the Federation of American Societies for Experimental BiologyAnimalsRespiratory Distress SyndromeMiceNanoparticlesButyric Acid
Innovative Butyric Acid Nanoparticle Therapy Restores Gut-Lung Axis and Suppresses PTPN1-Mediated Inflammation in Acute Respiratory Distress Syndrome.
Wenliang Zhu, Yue Wu, Xiaopei Huang, Shi Qiu, Huanzhang Shao
Published: 202510.1096/fj.202403391RRR
Abstract
Acute respiratory distress syndrome (ARDS) is a severe respiratory disorder characterized by systemic inflammation, pulmonary endothelial damage, and high mortality rates. Dysbiosis of gut microbiota has been identified as a key factor in the progres…
Preview only. Read the full abstract at the source